Health ❯ Healthcare ❯ Regulatory Approval

FDA

Drug Approval Process Biologics License Application Drug Development FluMist Approval Medical Devices Drug Marketing Medical Innovations Medical Device Approval Drug Safety Medication Approval Biologics Licensing Agreement Wegovy Label Expansion New Drug Approvals Clinical Trials Tirzepatide Clinical Research

Lilly Launches FDA-Cleared Monthly Zepbound KwikPen on LillyDirect at $299 Starter Price

The direct-to-consumer launch targets self-pay patients at a $299 starter price to expand choice.

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

Zydus to Commercialize FDA-Approved Interchangeable Lucentis Biosimilar NUFYMCO in U.S. Under Bioeq Deal

Lilly Files Orforglipron Obesity Pill With FDA After Trial Shows Weight-Loss Maintenance

FTC Files to Block Edwards Lifesciences’ $945 Million JenaValve Acquisition

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure